Cargando…

The impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy?

BACKGROUND: The glycoprotein MFG-E8 mediates phagocytic clearance of apoptotic cells and influences the pathogenesis and progression of inflammatory diseases. MFG-E8 was shown to attenuate the progression of inflammation and to improve survival in septic rats. Accumulating evidence suggests an immun...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Haese, Jan G, Demir, Ihsan Ekin, Kehl, Timo, Winckler, Jannik, Giese, Nathalia A, Bergmann, Frank, Giese, Thomas, Büchler, Markus W, Friess, Helmut, Hartel, Mark, Ceyhan, Güralp O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556065/
https://www.ncbi.nlm.nih.gov/pubmed/23324439
http://dx.doi.org/10.1186/1471-230X-13-14
_version_ 1782257136096509952
author D’Haese, Jan G
Demir, Ihsan Ekin
Kehl, Timo
Winckler, Jannik
Giese, Nathalia A
Bergmann, Frank
Giese, Thomas
Büchler, Markus W
Friess, Helmut
Hartel, Mark
Ceyhan, Güralp O
author_facet D’Haese, Jan G
Demir, Ihsan Ekin
Kehl, Timo
Winckler, Jannik
Giese, Nathalia A
Bergmann, Frank
Giese, Thomas
Büchler, Markus W
Friess, Helmut
Hartel, Mark
Ceyhan, Güralp O
author_sort D’Haese, Jan G
collection PubMed
description BACKGROUND: The glycoprotein MFG-E8 mediates phagocytic clearance of apoptotic cells and influences the pathogenesis and progression of inflammatory diseases. MFG-E8 was shown to attenuate the progression of inflammation and to improve survival in septic rats. Accumulating evidence suggests an immunomodulatory link between MFG-E8 and the pro-inflammatory chemokine fractalkine, which may determine the severity of pain, fibrosis, and inflammation in chronic pancreatitis (CP). METHODS: The expression and localization of MFG-E8 was investigated in CP (n = 62), and normal pancreas (NP; n = 34) by QRT-PCR, Western-blot and immunohistochemistry analyses. Results were correlated with mRNA expression of fractalkine, CX3CR1, and with the presence and degree of pain and fibrosis. Human pancreatic stellate cells (hPSCs) were isolated from CP tissues and evaluated for MFG-E8 mRNA expression after fractalkine stimulation. RESULTS: MFG-E8-mRNA was significantly overexpressed in CP and isolated hPSCs when compared to NP. Western-blot and immunohistochemistry analysis confirmed accumulation of MFG-E8 in CP, with noticeably increased MFG-E8 immunoreactivity in tubular complexes. MFG-E8 expression correlated significantly with fractalkine expression, severe fibrosis, and the presence of pain in CP patients. Stimulation of hPSCs with fractalkine led to a significant increase in MFG-E8 expression. CONCLUSIONS: In the present study, we demonstrated for the first time that MFG-E8 is significantly up-regulated in CP patients and together with fractalkine correlated noticeably with severe fibrosis and the presence of pain. hPSCs overexpress MFG-E8 upon fractalkine stimulation in vitro, which underlines the suggested immunmodulatory link in CP and may be a key mechanism in CP fibrogenesis and pain generation. Taken together, these novel findings suggest that MFG-E8 blockade may be a promising tool for future immunotherapy in CP to attenuate both fibrosis and pain sensation.
format Online
Article
Text
id pubmed-3556065
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35560652013-01-31 The impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy? D’Haese, Jan G Demir, Ihsan Ekin Kehl, Timo Winckler, Jannik Giese, Nathalia A Bergmann, Frank Giese, Thomas Büchler, Markus W Friess, Helmut Hartel, Mark Ceyhan, Güralp O BMC Gastroenterol Research Article BACKGROUND: The glycoprotein MFG-E8 mediates phagocytic clearance of apoptotic cells and influences the pathogenesis and progression of inflammatory diseases. MFG-E8 was shown to attenuate the progression of inflammation and to improve survival in septic rats. Accumulating evidence suggests an immunomodulatory link between MFG-E8 and the pro-inflammatory chemokine fractalkine, which may determine the severity of pain, fibrosis, and inflammation in chronic pancreatitis (CP). METHODS: The expression and localization of MFG-E8 was investigated in CP (n = 62), and normal pancreas (NP; n = 34) by QRT-PCR, Western-blot and immunohistochemistry analyses. Results were correlated with mRNA expression of fractalkine, CX3CR1, and with the presence and degree of pain and fibrosis. Human pancreatic stellate cells (hPSCs) were isolated from CP tissues and evaluated for MFG-E8 mRNA expression after fractalkine stimulation. RESULTS: MFG-E8-mRNA was significantly overexpressed in CP and isolated hPSCs when compared to NP. Western-blot and immunohistochemistry analysis confirmed accumulation of MFG-E8 in CP, with noticeably increased MFG-E8 immunoreactivity in tubular complexes. MFG-E8 expression correlated significantly with fractalkine expression, severe fibrosis, and the presence of pain in CP patients. Stimulation of hPSCs with fractalkine led to a significant increase in MFG-E8 expression. CONCLUSIONS: In the present study, we demonstrated for the first time that MFG-E8 is significantly up-regulated in CP patients and together with fractalkine correlated noticeably with severe fibrosis and the presence of pain. hPSCs overexpress MFG-E8 upon fractalkine stimulation in vitro, which underlines the suggested immunmodulatory link in CP and may be a key mechanism in CP fibrogenesis and pain generation. Taken together, these novel findings suggest that MFG-E8 blockade may be a promising tool for future immunotherapy in CP to attenuate both fibrosis and pain sensation. BioMed Central 2013-01-16 /pmc/articles/PMC3556065/ /pubmed/23324439 http://dx.doi.org/10.1186/1471-230X-13-14 Text en Copyright ©2013 D'Haese et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
D’Haese, Jan G
Demir, Ihsan Ekin
Kehl, Timo
Winckler, Jannik
Giese, Nathalia A
Bergmann, Frank
Giese, Thomas
Büchler, Markus W
Friess, Helmut
Hartel, Mark
Ceyhan, Güralp O
The impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy?
title The impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy?
title_full The impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy?
title_fullStr The impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy?
title_full_unstemmed The impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy?
title_short The impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy?
title_sort impact of mfg-e8 in chronic pancreatitis: potential for future immunotherapy?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556065/
https://www.ncbi.nlm.nih.gov/pubmed/23324439
http://dx.doi.org/10.1186/1471-230X-13-14
work_keys_str_mv AT dhaesejang theimpactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy
AT demirihsanekin theimpactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy
AT kehltimo theimpactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy
AT wincklerjannik theimpactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy
AT giesenathaliaa theimpactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy
AT bergmannfrank theimpactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy
AT giesethomas theimpactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy
AT buchlermarkusw theimpactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy
AT friesshelmut theimpactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy
AT hartelmark theimpactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy
AT ceyhanguralpo theimpactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy
AT dhaesejang impactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy
AT demirihsanekin impactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy
AT kehltimo impactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy
AT wincklerjannik impactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy
AT giesenathaliaa impactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy
AT bergmannfrank impactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy
AT giesethomas impactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy
AT buchlermarkusw impactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy
AT friesshelmut impactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy
AT hartelmark impactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy
AT ceyhanguralpo impactofmfge8inchronicpancreatitispotentialforfutureimmunotherapy